1Elevan Biopharmaceuticals Is Building the Infrastructure to Be the Partner of Choice for Peptide Medicine
The company is investing to be first-in-class in secure, legal, U.S.-based peptide manufacturing and dispensing — positioning it to serve patients and providers as an FDA advisory committee signals a widening lawful pathway for compounded peptides. FISHERS, Ind., Aug. 5, 2026 /PRNewswire/...
View original →